Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Teck Lim

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
Translational Lung Cancer Research|June 24, 2021
Complete disease remission in a <i>TP53</i> and <i>KRAS</i> co-mutated brain oligometastatic lung cancer patient after immuno-chemotherapy and surgical resection: a case reportShuai Zhu, Shikang Zhao, Qian Zhang, et al.
Oncotarget|March 20, 2016
Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancerChye Ling Tan, Tse Hui Lim, Tony Kh Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2011
A Phase II study of pazopanib in Asian patients with recurrent/metastatic nasopharyngeal carcinomaWan-Teck Lim, Quan-Sing Ng, Percy Ivy, et al.
Nature Communications|September 27, 2024
Magnetic augmentation through multi-gradient coupling enables direct and programmable profiling of circulating biomarkersYuan Chen, Li Zhang, Xingjie Wu, et al.
Molecular Cancer Therapeutics|February 8, 2022
A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody-Drug Conjugate Targeting P-Cadherin, in Patients With Solid TumorsMatteo Duca, Darren Wan-Teck Lim, Vivek Subbiah, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2015
Concurrent chemo-radiation with or without induction gemcitabine, Carboplatin, and Paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinomaTerence Tan, Wan-Teck Lim, Kam-Weng Fong, et al.
Scientific Reports|March 1, 2016
Microfluidic enrichment for the single cell analysis of circulating tumor cellsTrifanny Yeo, Swee Jin Tan, Chew Leng Lim, et al.
Cancer|February 3, 2015
Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysisN Gopalakrishna Iyer, Daniel S W Tan, Veronique K M Tan, et al.
Lab on a Chip|August 17, 2013
Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cellsMajid Ebrahimi Warkiani, Guofeng Guan, Khoo Bee Luan, et al.
Cancer Science|November 29, 2019
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohortsYung-Jue Bang, Wu-Chou Su, Martin Schuler, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Translational Lung Cancer Research|June 24, 2021
Complete disease remission in a <i>TP53</i> and <i>KRAS</i> co-mutated brain oligometastatic lung cancer patient after immuno-chemotherapy and surgical resection: a case reportShuai Zhu, Shikang Zhao, Qian Zhang, et al.
Oncotarget|March 20, 2016
Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancerChye Ling Tan, Tse Hui Lim, Tony Kh Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2011
A Phase II study of pazopanib in Asian patients with recurrent/metastatic nasopharyngeal carcinomaWan-Teck Lim, Quan-Sing Ng, Percy Ivy, et al.
Nature Communications|September 27, 2024
Magnetic augmentation through multi-gradient coupling enables direct and programmable profiling of circulating biomarkersYuan Chen, Li Zhang, Xingjie Wu, et al.
Molecular Cancer Therapeutics|February 8, 2022
A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody-Drug Conjugate Targeting P-Cadherin, in Patients With Solid TumorsMatteo Duca, Darren Wan-Teck Lim, Vivek Subbiah, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2015
Concurrent chemo-radiation with or without induction gemcitabine, Carboplatin, and Paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinomaTerence Tan, Wan-Teck Lim, Kam-Weng Fong, et al.
Scientific Reports|March 1, 2016
Microfluidic enrichment for the single cell analysis of circulating tumor cellsTrifanny Yeo, Swee Jin Tan, Chew Leng Lim, et al.
Cancer|February 3, 2015
Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysisN Gopalakrishna Iyer, Daniel S W Tan, Veronique K M Tan, et al.
Lab on a Chip|August 17, 2013
Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cellsMajid Ebrahimi Warkiani, Guofeng Guan, Khoo Bee Luan, et al.
Cancer Science|November 29, 2019
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohortsYung-Jue Bang, Wu-Chou Su, Martin Schuler, et al.
Pageof 14